Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 1–37 of 37 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05832320	Optimum Induction Therapy of Low-risk APL	unknown	N/A	74	Peking University People's HospitalOTHER	1	May 10, 2024	clinicaltrials
NCT03481868	EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors(EPIK)	unknown	N/A	160	University Hospital, Clermont-FerrandOTHER	1	Apr 9, 2024	clinicaltrials